BSE filing, NSE: HSCL. Summary written from the filing by ALFA Finder's alert engine.
Himadri Speciality Chemical Ltd: key numbers
- Share price
- ₹529.80
- Market cap
- ₹26,732 Cr
- Revenue (annual)
- ₹4,661 Cr
- Net profit (annual)
- ₹751.3 Cr
- P/E (TTM)
- 31.3×Sector 34.5×
- Promoter holding
- 52.49%-0.01% QoQ
- FII holding
- 7.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Himadri Speciality Chemical Ltd
All →Himadri Speciality Chemical Other Announcement
Himadri Speciality Chemical's members approved an alteration of its Memorandum of Association and adoption of a new MOA under the Companies Act, 2013. The approval was by special resolution through postal ballot on October 27, 2026.
Himadri Speciality Chemical Annual General Meeting
Himadri Speciality Chemical announced postal ballot results approving a special resolution to alter and adopt a new Memorandum of Association. Remote e-voting concluded 27 October 2026 with the requisite majority.
Himadri Speciality Chemical Earnings Call Transcript: Key Takeaways
Himadri delivered massive 58% revenue growth while maintaining steady margins despite high freight costs.
Himadri Speciality Chemical Investor Presentation: Key Takeaways
Himadri reported strong Q2 FY27 performance with revenue at ₹1,691 Cr and PAT at ₹231 Cr, driven by high-value product transitions and expansion into battery materials.
Himadri Speciality Chemical Results Update
Himadri Speciality Chemical reported consolidated H1FY27 revenue of ₹3,123 Cr and PAT of ₹460 Cr, reflecting growth across its specialty chemicals and battery material portfolios.
Himadri Speciality Chemical Q2 FY27 Results: Net Profit ₹231.3 Cr, Up 31.3% YoY
Himadri Speciality Chemical Ltd reported revenue from operations of ₹1,691 Cr (+57.9% YoY) and net profit of ₹231.3 Cr (+31.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹231.3 Cr · +31.3% YoY
Other board meeting date announcements
All →Jetking Infotrain Board Meeting Date
Jetking Infotrain has scheduled a board meeting on November 4, 2026 to consider unaudited quarterly and half-year results. The trading window remains closed until 48 hours after the results announcement.
Metropolis Healthcare Board Meeting Date
Metropolis Healthcare intimated a board meeting on November 3, 2026 to consider Q2 and half-year unaudited results and possible interim dividend. Trading window is closed October 1 to November 5, 2026.
Aelea Commodities Board Meeting Date
Aelea Commodities has scheduled a board meeting for 2 November 2026 to consider half-year results and other items. The agenda includes an additional independent director, a director resignation, and business expansion and capex.
R Systems International Board Meeting Date
R Systems International will hold a board meeting on 3 November 2026 to consider quarterly and nine-month results to September 2026. The trading window remains closed until 48 hours after the results are declared.
Onida Electronics Board Meeting Date
Onida Electronics schedules a 3 November 2026 board meeting for Q2 and half-year results and ESOP share allotment. Trading window stays closed until 48 hours post-results.
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.